Total submissions: 1
| Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
|---|---|---|---|---|---|---|---|---|
| Laboratory for Molecular Medicine, |
RCV000037732 | SCV000061394 | uncertain significance | not specified | 2011-12-19 | criteria provided, single submitter | clinical testing | Variant classified as Uncertain Significance - Favor Pathogenic. The Glu428Gln v ariant has not been reported in the literature nor been identified by our labora tory. Glutamic acid (Glu) at this residue is highly conserved across evolutiona rily distant species, suggesting that a change to the amino acid may not be tole rated. Furthermore, it has been reported that the glutamic acid at position 428 is conserved across the TGF-B family of proteins and this residue creates a sal t bridge with the arginine at position 528 (Horbelt 2010). Pathogenic variants at the Arg528 residue have been reported and due to the reported structural inte raction of these two residues, it is possible that a change to the Gly428 positi on may also impact the protein. Computation tools (PolyPhen-2 and SIFT) predict that this variant will impact the protein but it should be noted that the accur acy of these prediction tools is unknown. Although this information may be sugg estive of a pathogenic role, the clinical significance of this variant cannot be determined at this time in the absence of additional information such as contro l studies, segregation data, or functional analyses. |